Secondary analysis of the phase 2 PEACE V-STORM trial (190 evaluable patients with nodal oligorecurrent prostate cancer): quality of life over a median 50 months did not differ significantly between elective nodal radiotherapy plus ADT and metastasis-directed therapy.
Secondary analysisn = 196
Zilli et al. Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial